HLAthena
Presentation predictor trained on the mono-allelic peptidome of 95 cell lines — 186,464 peptides across 95 HLA alleles, fifteen of which had no described motif before — which is the dataset that changed this field more than any architectural idea.
At a glance
What it does
Scores peptide–allele pairs and adds features beyond the peptide: gene expression of the source protein and cleavage context, which is why its predictions track real presentation more closely than binding-only tools.
Notable uses in oncology
The underlying allele panel covers at least one allele in 95% of people worldwide for each of HLA-A, -B and -C — the reason the 'long tail' of alleles shrank at all.
Tasks, data types and cancers
Architecture
Adding expression is what a peptide-only model structurally cannot do; the price is that you need RNA data for the sample.
Training data
95 mono-allelic B721.221 lines (31 HLA-A, 40 HLA-B, 21 HLA-C, 3 HLA-G), 186,464 unique peptides, median 1,860 per allele.
Linked datasets
- training Mono-allelic HLA class I peptidome (Sarkizova / Abelin) Open download — this model and this dataset come from the same paper
Evaluation
| Benchmark / dataset | Metric | Value | External validation | Source |
|---|---|---|---|---|
| top 0.1% of a 1:999 decoy list | PPV | reported by the authors at 1:999 — a stricter setup than several competitors use | no | Source |
How to run
No standalone weights; use the web tool or reuse the published peptidome (see the data card) to train your own model.
Regulatory status and intended use
Regulatory status is quoted from the source linked above and can change. Research-use-only models must not be used for clinical decisions.
Limitations and bias
- Web-only: not embeddable in an offline pipeline.
- Expression features require matched RNA data, so it is not a universal 'peptide in, score out' tool.
Sources
This page is educational — it is not medical advice and does not replace consultation with an oncologist. Diagnostic and treatment decisions are made solely by specialist physicians.